Literature DB >> 19224757

Herpes zoster in the age of focused immunosuppressive therapy.

Richard J Whitley, John W Gnann.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19224757     DOI: 10.1001/jama.2009.150

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.

Authors:  Shih Hann Su; Valérie Martel-Laferrière; Annie-Claude Labbé; David R Snydman; David Kent; Michel Laverdière; Claire Béliveau; Tanya Logvinenko; Sandra Cohen; Silvy Lachance; Thomas Kiss; Jean Roy
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-25       Impact factor: 5.742

2.  In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.

Authors:  G Andrei; D Topalis; P Fiten; C McGuigan; J Balzarini; G Opdenakker; R Snoeck
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

3.  The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.

Authors:  Jie Zhang; Elizabeth Delzell; Fenglong Xie; John W Baddley; Claire Spettell; Raechele M McMahan; Joaquim Fernandes; Lang Chen; Kevin Winthrop; Jeffrey R Curtis
Journal:  Arthritis Res Ther       Date:  2011-10-24       Impact factor: 5.156

4.  Herpes zoster is associated with prior statin use: a population-based case-control study.

Authors:  Shiu-Dong Chung; Ming-Chieh Tsai; Shih-Ping Liu; Herng-Ching Lin; Jiunn-Horng Kang
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.